solfataricus was primarily in the disulfide form
BPC-157 works through at least five confirmed molecular mechanisms: eNOS upregulation increasing nitric oxide (L-NAME blockade confirms NO-dependence), VEGFR2 upregulation driving angiogenesis (+44% CD31+ microvessel density, abolished by anti-VEGFR2 antibody), FAK-paxillin pathway activation driving cell migration (+3852% scratch closure, abolished by FAK inhibitor), growth hormone receptor sensitisation relevant to tendon-to-bone healing, and NF-B suppression reducing TNF- and IL-6
Scheme 10
Scientists have not given up on the drugs for these conditions, but they will need to pivot, focusing on new GLP-1 research questions spurred by the trials results
Lee HJ, Ha SJ, Lee SJ, Kim JW
In people with slower ALDH activity, acetaldehyde accumulates, prolonging oxidative stress and amplifying the inflammatory response